National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 17312 [2022-06376]
Download as PDF
<![CDATA[
17312
Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group; Career
Development Facilitating The Transition to
Independence Study Section.
Date: June 9–10, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging Gateway
Building 7201 Wisconsin Avenue Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: NIJAGUNA PRASAD,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
7201 Wisconsin Avenue, Gateway Bldg, Suite
2W200, Bethesda, MD 20892, (301) 496–
9667, prasadnb@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Digestive Diseases
Research Core Centers (P30).
Date: July 14–15, 2022.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, 6707 Democracy Blvd., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, Division of
Extramural Activities, NIDDK, National
Institutes of Health, Room 7011, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7799 yangj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 22, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–06376 Filed 3–25–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Refugee Resettlement
Dated: March 22, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Extending Refugee Cash Assistance
and Refugee Medical Assistance From
8 Months to 12 Months
[FR Doc. 2022–06372 Filed 3–25–22; 8:45 am]
AGENCY:
Office of Refugee Resettlement
(ORR), Administration for Children and
Families (ACF), Department of Health
and Human Services (HHS).
ACTION: Notice of change of eligibility
period.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
17:30 Mar 25, 2022
Jkt 256001
In accordance with ORR
regulations, the Director of ORR is
announcing the expansion of the
Refugee Cash Assistance (RCA) and
Refugee Medical Assistance (RMA)
eligibility period from 8 months to 12
months of assistance for participants
whose date of eligibility for ORR
benefits is on or after October 1, 2021.
Through the Refugee Act of 1980,
Congress authorized cash and medical
assistance up to 36 months, yet by fiscal
year (FY) 1992, mainly due to
insufficient appropriations, ORR had
SUMMARY:
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
jspears on DSK121TN23PROD with NOTICES1
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
reduced the RCA and RMA eligibility
periods to 8 months. For 30 years, ORR
has not increased the RCA or RMA
eligibility period. Extending the RCA
and RMA eligibility period will lead to
more effective resettlement, by
providing refugee and other ORReligible populations with additional
time to become self-sufficient.
DATES: The changes described in this
Federal Register notice are effective as
of the date of publication.
FOR FURTHER INFORMATION CONTACT:
Colleen Mahar-Piersma, Refugee Policy
Unit, Division of Policy and Procedures,
Office of the Director, Office of Refugee
Resettlement, Administration for
Children and Families, by phone at
(202) 260–5493, and email at
refugeepolicy@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: The 1980
Refugee Act (8 U.S.C. 1522(e)(1))
authorized the Director of ORR
(hereinafter ‘‘the Director’’) to provide
RCA and RMA during the first 36
months after a refugee’s arrival in the
United States or, for other ORR-eligible
populations, after they became eligible
for ORR benefits and services. (ORReligible populations, hereinafter referred
to as ‘‘refugees,’’ are outlined within
ORR Policy Letter (PL) 16–01,
Documentation Requirements for the
Refugee Resettlement Program and ORR
PL 22–02, Additional ORR-Eligible
Statuses and Categories and Acceptable
Documentation Requirements for
Afghan Nationals.)
ORR regulations (45 CFR 400.211(a))
authorize the Director to determine the
time-eligibility period for RCA and
RMA each year based on the
appropriated funds available for the
fiscal year. After Congress passed the
Refugee Act of 1980, ORR provided
refugees with RCA and RMA for the first
36 months after a refugee’s arrival.
However, due to reduced
appropriations, ORR had to decrease
this assistance from 36 months to 18
months, then to 12 months, and finally,
in FY 1992, to 8 months.
The proposed expansion of the RCA
and RMA eligibility period would
positively impact refugees who are not
eligible for Temporary Assistance for
Needy Families or Medicaid. Increasing
the RCA and RMA eligibility period
enables refugees to address any medical
and mental health issues that would
impede their ability to become selfsufficient. Additionally, an expanded
eligibility period allows refugees to
focus on the Congressional priorities for
assistance, as outlined in the Refugee
Act, of acquiring English, receiving
employment training, and securing
employment, with the increase in
E:\FR\FM\28MRN1.SGM
28MRN1
]]>Agencies
[Federal Register Volume 87, Number 59 (Monday, March 28, 2022)]
[Notices]
[Page 17312]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06376]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Digestive Diseases
Research Core Centers (P30).
Date: July 14-15, 2022.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, NIDDK, 6707 Democracy
Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Yang, Ph.D., Scientific Review Officer,
Review Branch, Division of Extramural Activities, NIDDK, National
Institutes of Health, Room 7011, 6707 Democracy Boulevard, Bethesda,
MD 20892-5452, (301) 594-7799 [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: March 22, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-06376 Filed 3-25-22; 8:45 am]
BILLING CODE 4140-01-P
